You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Details for New Drug Application (NDA): 022288


✉ Email this page to a colleague

« Back to Dashboard


NDA 022288 describes BEPREVE, which is a drug marketed by Bausch And Lomb Inc and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the BEPREVE profile page.

The generic ingredient in BEPREVE is bepotastine besilate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bepotastine besilate profile page.
Summary for 022288
Tradename:BEPREVE
Applicant:Bausch And Lomb Inc
Ingredient:bepotastine besilate
Patents:1
Pharmacology for NDA: 022288
Suppliers and Packaging for NDA: 022288
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BEPREVE bepotastine besilate SOLUTION/DROPS;OPHTHALMIC 022288 NDA Bausch & Lomb Incorporated 24208-629 24208-629-01 1 BOTTLE, DROPPER in 1 CARTON (24208-629-01) / 10 mL in 1 BOTTLE, DROPPER
BEPREVE bepotastine besilate SOLUTION/DROPS;OPHTHALMIC 022288 NDA Bausch & Lomb Incorporated 24208-629 24208-629-02 1 BOTTLE, DROPPER in 1 CARTON (24208-629-02) / 5 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength1.5%
Approval Date:Sep 8, 2009TE:ATRLD:Yes
Patent:⤷  Try a TrialPatent Expiration:Jan 13, 2025Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 022288

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch And Lomb Inc BEPREVE bepotastine besilate SOLUTION/DROPS;OPHTHALMIC 022288-001 Sep 8, 2009 ⤷  Try a Trial ⤷  Try a Trial
Bausch And Lomb Inc BEPREVE bepotastine besilate SOLUTION/DROPS;OPHTHALMIC 022288-001 Sep 8, 2009 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.